Synthesis, characterisation and enhanced apoptotic effect of gemcitabine-loaded albumin nanoparticles coating with chitosan

References

• Abbasi, S., et al., 2012. Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment. Journal of drug delivery, 2012, 1–8.
   Google Scholar
• Aiping, Z., Jianhong, L., and Wenhui, Y., 2006. Effective loading and controlled release of camptothecin by O-carboxymethyl chitosan aggregates. Carbohydrate polymers, 63 (1), 89–96.
   Web of Science ®Google Scholar
• Al-Hazzani, A.A., and Alshatwi, A.A., 2011. Catechin hydrate inhibits proliferation and mediates apoptosis of SiHa human cervical cancer cells. Food and chemical toxicology, 49 (12), 3281–3286.
   PubMed Web of Science ®Google Scholar
• Almalik, A., et al., 2013. Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation. Journal of controlled release, 172 (3), 1142–1150.
   PubMed Web of Science ®Google Scholar
• Arya, G., et al., 2011. Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. Nanomedicine: nanotechnology, biology and medicine, 7 (6), 859–870.
   PubMed Web of Science ®Google Scholar
• Brahatheeswaran, D., et al., 2012. Hybrid fluorescent curcumin loaded zein electrospun nanofibrous scaffold for biomedical applications. Biomedical materials, 7 (4), 045001.
   PubMed Web of Science ®Google Scholar
• Cho, K., et al., 2008. Therapeutic nanoparticles for drug delivery in cancer. Clinical cancer research, 14 (5), 1310–1316.
   PubMed Web of Science ®Google Scholar
• Chomczynski, P., and Sacchi, N., 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical biochemistry, 162 (1), 156–159.
   PubMed Web of Science ®Google Scholar
• Circu, M.L., and Yee Aw, T., 2008. Glutathione and apoptosis. Free radical research, 42 (8), 689–706.
   PubMed Web of Science ®Google Scholar
• Cohen, S., et al., 2013. Synthesis and characterization of near IR fluorescent albumin nanoparticles for optical detection of colon cancer. Materials science and engineering: C, 33 (2), 923–931.
   PubMed Web of Science ®Google Scholar
• Dumont, V.C., et al., 2016. Chitosan and carboxymethyl-chitosan capping ligands: Effects on the nucleation and growth of hydroxyapatite nanoparticles for producing biocomposite membranes. Materials science and engineering: C, 59, 265–277.
   PubMed Web of Science ®Google Scholar
• El-Dayem, S.M.A., et al., 2013. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice. Toxicology and industrial health, 29 (5), 404–417.
   PubMed Web of Science ®Google Scholar
• Ellman, G.L., 1959. Tissue sulfhydryl groups. Archives of biochemistry and biophysics, 82 (1), 70–77.
   PubMed Web of Science ®Google Scholar
• Esfandyari-Manesh, M., et al., 2016. Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer. International journal of pharmaceutics, 515 (1-2), 607–615.
   PubMed Web of Science ®Google Scholar
• Fuertes, M.B., et al., 2004. Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70 S6 kinase. Molecular and cellular biochemistry, 267 (1/2), 177–185.
   PubMed Web of Science ®Google Scholar
• Fujita, H., et al., 2010. Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia, 12 (10), 807–817.
   PubMed Web of Science ®Google Scholar
• Galmarini, C.M., Mackey, J.R., and Dumontet, C., 2002. Nucleoside analogues and nucleobases in cancer treatment. The lancet oncology, 3 (7), 415–424.
   PubMed Web of Science ®Google Scholar
• Gautam, A., Li, Z.-R., and Bepler, G., 2003. RRM1-induced metastasis suppression through PTEN-regulated pathways. Oncogene, 22 (14), 2135–2142.
   PubMed Web of Science ®Google Scholar
• Gurunathan, S., et al., 2013. Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells. International journal of nanomedicine, 8, 4399–4413.
   PubMed Web of Science ®Google Scholar
• Harush-Frenkel, O., et al., 2008. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules, 9 (2), 435–443.
   PubMed Web of Science ®Google Scholar
• Hussain, S., et al., 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicology in vitro, 19 (7), 975–983.
   PubMed Web of Science ®Google Scholar
• Itoh, G., et al., 1995. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. The American journal of pathology, 146 (6), 1325–1331.
   PubMed Web of Science ®Google Scholar
• Keith, B., Xu, Y., and Grem, J.L., 2003. Measurement of the anti-cancer agent gemcitabine in human plasma by high-performance liquid chromatography. Journal of chromatography B: analytical technologies in the biomedical and life sciences, 785 (1), 65 –72.
   Google Scholar
• Khare, V., et al., 2014. Targeted drug delivery systems for pancreatic cancer. Journal of biomedical nanotechnology, 10 (12), 3462–3482.
   PubMed Web of Science ®Google Scholar
• Kohler, N., et al., 2005. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir, 21 (19), 8858–8864.
   PubMed Web of Science ®Google Scholar
• Langer, K., et al., 2008. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation. International journal of pharmaceutics, 347 (1-2), 109–117.
   PubMed Web of Science ®Google Scholar
• Li, J.-M., et al., 2009. Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro. Acta pharmacologica sinica, 30 (9), 1337–1343.
   PubMed Web of Science ®Google Scholar
• Mini, E., et al., 2006. Cellular pharmacology of gemcitabine. Annals of oncology, 17, v7–v12.
   PubMed Web of Science ®Google Scholar
• Misak, H.E., et al., 2014. Albumin‐based nanocomposite spheres for advanced drug delivery systems. Biotechnology journal, 9 (1), 163–170.
   PubMed Web of Science ®Google Scholar
• Moghimi, S.M., Hunter, A.C., and Murray, J.C., 2001. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacological reviews, 53 (2), 283–318.
   PubMed Web of Science ®Google Scholar
• Patil, S., et al., 2007. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials, 28 (31), 4600–4607.
   PubMed Web of Science ®Google Scholar
• Qu, N., et al., 2019. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation. Biomedical engineering online, 18 (1), 11.
   PubMedGoogle Scholar
• Sahay, G., Alakhova, D.Y., and Kabanov, A.V., 2010. Endocytosis of nanomedicines. Journal of controlled release, 145 (3), 182–195.
   PubMed Web of Science ®Google Scholar
• Sebak, S., et al., 2010. Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis. International journal of nanomedicine, 5, 525–532.
   PubMed Web of Science ®Google Scholar
• Vandana, M., and Sahoo, S.K., 2010. Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer. Biomaterials, 31 (35), 9340–9356.
   PubMed Web of Science ®Google Scholar
• Xu, R., Fisher, M., and Juliano, R., 2011. Targeted albumin-based nanoparticles for delivery of amphipathic drugs. Bioconjugate chemistry, 22 (5), 870–878.
   PubMed Web of Science ®Google Scholar
• Yang, H., et al., 2018. The role of cellular reactive oxygen species in cancer chemotherapy. Journal of experimental & clinical cancer research, 37, 266.
   PubMed Web of Science ®Google Scholar
• Yardley, D.A., 2005. Gemcitabine plus paclitaxel in breast cancer. Seminars in oncology, 32, 14–21.
   Web of Science ®Google Scholar
• Zhou, B., et al., 2013. A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance. Cancer research, 73 (21), 6484–6493.
   PubMed Web of Science ®Google Scholar